Raleigh Capital Management’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-252
Closed -$15.7K 1091
2023
Q3
$15.7K Buy
252
+7
+3% +$471 0.01% 430
2023
Q2
$18.1K Buy
245
+37
+18% +$2.82K 0.01% 402
2023
Q1
$16.4K Buy
+208
New +$15K 0.01% 406

Other funds holding BRKR

Raleigh Capital Management's BRKR Position: Q4 2023 in Review

Raleigh Capital Management sold out of Bruker (BRKR) in Q4 2023, closing a stake of 252 shares — an estimated $15.7K sold.

Raleigh Capital Management first reported a position in BRKR in Q1 2023 and held it in 3 quarters. The position peaked at $18.1K in Q2 2023. 360 funds tracked by Wall St. Rank hold BRKR as of Q4 2023.

  • Raleigh Capital Management reported no remaining Bruker position as of Q4 2023 after selling out during the quarter.
  • Raleigh Capital Management sold 252 Bruker shares in Q4 2023, an estimated $15.7K.
  • Raleigh Capital Management first reported a position in Bruker in Q1 2023 and held it in 3 quarters.
  • Raleigh Capital Management's Bruker position peaked at $18.1K in Q2 2023.
  • 360 funds tracked by Wall St. Rank held Bruker as of Q4 2023.

Based on Raleigh Capital Management's 13F filing for Q4 2023, filed 21 Feb 2024.